<?xml version="1.0" encoding="UTF-8"?>
<p>The shifting viral strain is one of the key factors associated with the pandemic. After observed a number of infections in spring 2009, a new H1N1 virus had been identified. The viral strain had been spread globally, but it was not included in the regular seasonal vaccine. Because the production of the seasonal vaccine already started, vaccine manufacturers were unable to alter vaccine products to include the new viral strain. The influenza-like illness (ILI) defines as the acute respiratory infection with the symptom of a cough and a fever of ≥ 38 C°(
 <xref rid="ref-32" ref-type="bibr">World Health Organization, 2018</xref>). There were a large number of clinical visits for ILI before the monovalent vaccine was available in early November. The H1N1 outbreak continued the following year, and there were sporadic infections during the post-pandemic period (
 <xref rid="ref-11" ref-type="bibr">Chuang et al., 2012</xref>; 
 <xref rid="ref-7" ref-type="bibr">Centers for Disease Control, 2017b</xref>). Although the new H1N1 virus caused a large size outbreak in 2009, the epidemic caused less mortality than an average season due to many infections occurred in the younger population. Therefore, the World Health Organization (WHO) defined the pandemic as a moderate severity level (
 <xref rid="ref-31" ref-type="bibr">World Health Organization, 2009</xref>).
</p>
